C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors Novartis Ag Transaction History
C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors
- $905 Billion
- Q2 2024
A detailed history of C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors transactions in Novartis Ag stock. As of the latest transaction made, C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors holds 5,507 shares of NVS stock, worth $642,391. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,507
Previous 8,196
32.81%
Holding current value
$642,391
Previous $793 Million
26.05%
% of portfolio
0.06%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$865 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$864 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$694 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...